Pacific Biosciences of California, Inc.
PACB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001299130
In the last 90 days, Pacific Biosciences of California, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $320.8M in total; superinvestors ARK Invest and HHLR Advisors (Hillhouse) hold it.
13F holders, Q3 2024
Institutional positions in Pacific Biosciences of California, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 226
- −1 vs. Q2 2024
- Shares held
- 231.9M
- +13.3M (+6.1%) vs. Q2 2024
- Total value
- $394.3M
- +$94.9M (+31.7%) vs. Q2 2024
- New holders
- 24
- 69 more added
- Sold out
- 25
- 76 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PACB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 223 | $320.8M |
| Q1 2026 | 231 | $248.5M |
| Q4 2025 | 216 | $373.5M |
| Q3 2025 | 208 | $237.8M |
| Q2 2025 | 207 | $245.8M |
| Q1 2025 | 225 | $265.6M |
| Q4 2024 | 227 | $475.1M |
| Q3 2024 | 226 | $394.3M |
| Q2 2024 | 229 | $331.9M |
| Q1 2024 | 268 | $1.01B |
| Q4 2023 | 274 | $2.76B |
| Q3 2023 | 275 | $2.20B |
| Q2 2023 | 272 | $3.37B |
| Q1 2023 | 260 | $2.93B |
| Q4 2022 | 237 | $1.84B |
| Q3 2022 | 227 | $1.23B |
| Q2 2022 | 230 | $1.03B |
| Q1 2022 | 250 | $2.03B |
| Q4 2021 | 256 | $4.20B |
| Q3 2021 | 246 | $4.83B |
| Q2 2021 | 261 | $6.04B |
| Q1 2021 | 263 | $5.47B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Pacific Biosciences of California, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Senvest Management, LLC | 1,093,954 | $1.86M | 0.06% | +290,000+36.1% | Added |
| VK Services, LLC | 1,316,393 | $2.24M | 0.49% | −1,316,391−50.0% | Reduced |
| Susquehanna International Group, LLP | 1,728,864 | $2.94M | 0.00% | +911,103+111.4% | Added |
| Price T Rowe Associates Inc | 1,838,752 | $3.13M | 0.00% | −100,482−5.2% | Reduced |
| Charles Schwab Investment Management Inc | 2,040,303 | $3.47M | 0.00% | +82,807+4.2% | Added |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 2,098,000 | $3.57M | 0.07% | +400,000+23.6% | Added |
| Marshall Wace, LLP | 2,121,920 | $3.61M | 0.00% | +510,620+31.7% | Added |
| Bank of America Corp | 2,353,847 | $4.00M | 0.00% | +489,954+26.3% | Added |
| Northern Trust Corp | 2,357,679 | $4.01M | 0.00% | −146,597−5.9% | Reduced |
| Jane Street Group, LLC | 2,671,269 | $4.54M | 0.01% | +966,778+56.7% | Added |
| Capital World Investors | 3,390,000 | $5.76M | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,892,542 | $6.62M | 0.00% | +812,786+26.4% | Added |
| Goldman Sachs Group Inc | 4,238,267 | $7.21M | 0.00% | +255,702+6.4% | Added |
| Bank of New York Mellon Corp | 5,573,167 | $9.47M | 0.00% | −4,362,004−43.9% | Reduced |
| State Street Corp | 6,276,156 | $10.7M | 0.00% | +340,766+5.7% | Added |
| Jackson Square Partners, LLC | 6,296,116 | $10.7M | 0.92% | −2,587,327−29.1% | Reduced |
| Geode Capital Management, LLC | 6,327,906 | $10.8M | 0.00% | +225,034+3.7% | Added |
| Millennium Management LLC | 10,422,578 | $17.7M | 0.02% | +5,792,951+125.1% | Added |
| Nikko Asset Management Americas, Inc. | 11,865,766 | $20.1M | 0.23% | −774,795−6.1% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 11,865,766 | $20.2M | 0.01% | −774,795−6.1% | Reduced |
| Vanguard Group Inc | 17,642,804 | $30.0M | 0.00% | −8,356,139−32.1% | Reduced |
| Edmond de Rothschild Holding S.A. | 20,307,880 | $34.5M | 0.56% | +3,571,460+21.3% | Added |
| BlackRock, Inc. | 23,252,682 | $39.5M | 0.00% | +23,252,682 | New |
| Madrone Advisors, LLC | 23,391,915 | $39.8M | 6.35% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 33,406,401 | $56.8M | 0.52% | +193,947+0.6% | Added |
| EMC Capital Management | 13,831 | – | – | −43,654−75.9% | Reduced |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −1,645,499−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −1,213,637−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −595,874−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −274,488−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −108,680−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −102,260−100.0% | Sold out |
| Lombard Odier Asset Management (USA) Corp | 0 | $0 | 0.00% | −94,557−100.0% | Sold out |
| Private Wealth Partners, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −26,479−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −20,971−100.0% | Sold out |
| SVB Financial Group | 0 | $0 | 0.00% | −20,586−100.0% | Sold out |
| BI Asset Management Fondsmaeglerselskab A/S | 0 | $0 | 0.00% | −15,996−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −14,530−100.0% | Sold out |
| Byrne Asset Management LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −7,300−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −3,491−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −644−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −517−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Dunhill Financial, LLC | 0 | $0 | 0.00% | −189−100.0% | Sold out |
| Sittner & Nelson, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |